Pure Global
NCT06381765

Serratus Plane Block and Pectointercostal Block

Comparison of Deep Serratus Plane Block With Deep Serratus Plane Block+Pectointercostal Plane Block
Cukurova University·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Postoperative Pain
Drug/Device/Intervention
ultrasound guided Serratus plane bock and pectointercostal block
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Cukurova University
Location
Adana, Turkey
Timeline & enrollment
Phase
N/A
Start date
May 10, 2024
End date
Aug 10, 2024
Enrollment
60 participants
Primary outcome

postoperative morphine consumption,postoperative visual analog scale scores

Summary

ASA I-II female patients aged over 18 who will undergoing breast reduction surgery will
 recruit to the study. Patients will divide into 2 groups. Deep serratus plane block will
 perform with 0,25 %bupivacaine 20 ml at the midaxillary 5. rib, bilaterally for Group I. At
 Group II, deep serratus plane block ( 0,25 %bupivacaine 20 ml) at the midaxillary 5.th rib+
 pectointercostal plane block (0,25% bupivacaine 15 ml) at 4-5.th intercostal space will
 perform bilaterally . General anesthesia with sevoflurane and remifentanil will perform to
 the all patients. Postoperative pain scores, morphine consumption and complications will
 record till the 24.th hours.

ICD-10 classifications
Acute painPostoperative intestinal obstructionPain, unspecifiedDuring surgical operationDuring surgical operation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06381765
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06381765 through Pure Global AI's free database. This phase not specified trial is sponsored by Cukurova University and is currently Recruiting. The study focuses on Postoperative Pain. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.